Once-monthly oral ibandronate (boniva) has favorable safety and tolerability in postmenopausal women with osteoporosis: 2-year results from MOBILE.

被引：0
|
作者：
Greenwald, M
Hawker, G
Cooper, C
Hughes, C
Mairon, N
Bonvoisin, B
Silverman, S
机构：
[1] Desert Med Adv, Palm Desert, CA USA
[2] Sunnybrook & Womens Coll Hosp, Toronto, ON, Canada
[3] Univ Southampton, MRC, Epidemiol Resource Ctr, Southampton SO9 5NH, Hants, England
[4] F Hoffmann La Roche & Co Ltd, CH-4002 Basel, Switzerland
[5] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
来源：
ARTHRITIS AND RHEUMATISM | 2005年 / 52卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S297 / S297
页数：1
相关论文
共 50 条
  • [31] Once-monthly oral ibandronate compared with weekly oral alendronate in postmenopausal osteoporosis: results from the head-to-head MOTION study
    Miller, Paul D.
    Epstein, Sol
    Sedarati, Farhad
    Reginster, Jean-Yves
    CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (01) : 207 - 213
  • [32] Monthly oral ibandronate therapy in postmenopausal osteoporosis: 1-year results from the MOBILE study
    Miller, PD
    McClung, MR
    Macovei, LV
    Stakkestad, JA
    Luckey, M
    Bonvoisin, B
    Reginster, JY
    Recker, RR
    Hughes, C
    Lewiecki, EM
    Felsenberg, D
    Delmas, PD
    Kendler, DL
    Bolognese, MA
    Mairon, N
    Cooper, C
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (08) : 1315 - 1322
  • [33] Efficacy and Tolerability of Once-Monthly Oral Ibandronate (150 mg) and Once-Weekly Oral Alendronate (70 mg): Additional Results From the Monthly Oral Therapy With Ibandronate for Osteoporosis Intervention (MOTION) Study
    Emkey, Ronald
    Delmas, Pierre D.
    Bolognese, Michael
    Borges, Lindolfo C.
    Cosman, Felicia
    Ragi-Eis, Sergio
    Recknor, Christopher
    Zerbini, Cristiano A.
    Neate, Colin
    Sedarati, Farhad
    Epstein, Solomon
    CLINICAL THERAPEUTICS, 2009, 31 (04) : 751 - 761
  • [34] Daily and once-monthly oral ibandronate have similar safety profiles in elderly and younger women: 1-year results from the mobile study.
    Miller, P
    Lewiecki, M
    Sol, E
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2005, 53 (04) : S194 - S194
  • [35] Once monthly dosing increases the proportion of patients who respond to oral ibandronate: 1-year results from MOBILE.
    Emkey, R
    Felsenberg, D
    Stepan, JJ
    Hughes, C
    Dumont, E
    Van der Auwera, P
    Recker, RR
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S447 - S447
  • [36] Monthly oral ibandronate is effective and safe therapy for women with postmenopausal osteoporosis: Mobile 1-year results.
    Epstein, S
    Bolognese, MA
    Miller, P
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2005, 53 (04) : S196 - S196
  • [37] Efficacy and tolerability of intravenous ibandronate injections in postmenopausal osteoporosis: 2-year results from the DIVA study
    Eisman, John A.
    Civitelli, Roberto
    Adaml, Silvano
    Czerwinski, Edward
    Recknor, Chris
    Prince, Richard
    Reginster, Jean-Yves
    Zaidi, Mone
    Felsenberg, Dieter
    Hughes, Claire
    Mairon, Nicole
    Masanauskaite, Daiva
    Reid, David M.
    Delmas, Pierre D.
    Recker, Robert R.
    JOURNAL OF RHEUMATOLOGY, 2008, 35 (03) : 488 - 497
  • [38] Efficacy and Tolerability of Intravenous Ibandronate Injections in Postmenopausal Osteoporosis: 2-Year Results from the DIVA Study
    Mikosch, P.
    JOURNAL FUR MINERALSTOFFWECHSEL, 2008, 15 (03): : 159 - +
  • [39] Hip Structural Analysis Based on DXA Data in Women with Postmenopausal Osteoporosis Receiving Once-Monthly Oral Ibandronate for 12 Months
    Lewieeki, E. M.
    Genant, H. K.
    Engelke, K.
    Fuerst, F.
    Fries, M.
    Enslin, M.
    Fitzpatrick, L. A.
    Kivitz, A.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S229 - S229
  • [40] Monthly oral ibandronate is at least as effective as daily oral ibandronate in increasing hip BMD in postmenopausal osteoporosis: 1-year results from mobile
    Cooper, C
    Stepan, JJ
    Lorenc, R
    Hughes, C
    Mairon, N
    Sedarati, F
    Reginster, JY
    BONE, 2005, 36 : S417 - S417
12345